Thanks for your interest in the ADPKD Referral tool. We are helping connect referring doctors to specialists interested in caring for patients with autosomal dominant polycystic kidney disease (ADPKD).
Are you interested in being added as a provider, click below to update us with your office/clinic information
Demo Login
Nephrology Ask the Experts
UKidney answers your nephrology questions! Feel free to search our previous submissions or create your own today.
Hi! Dr Weinstein, Is it now official that Eculizumab is approved in Ontario for treatment of aHUS, would OHIP only patients (without private insurance) benefit, does one have to establish the compliment mutations to be an eligible candidate.
According to the company, although the drug is indeed approved for usage in aHUS, coverage is determined on a case-by-case basis. And no, approval does not depend on the demonstration of a mutation; demonstrable mutations are often absent in aHUS in 30-50% of cases, making the diagnosis a combination of both clinical and laboratory parameters.
You are logged in with standard UKidney account. In some cases, UKidney content is restricted to verified Healthcare Providers (HCPs) only.
If you would like to upgrade your account to a UKidney Verified Profile, please click below. There is no cost to do this but proof of HCP status is requried.
ukidneyisup
You are now being logged in using your Facebook credentials